In Vitro Technologies partners with Novus Biologicals in ANZ
In Vitro Technologies has been announced as the distributor for Novus Biologicals in Australia and New Zealand as of 1 July 2015.
Novus Biologicals, a Bio-Techne brand, is committed to providing researchers with a comprehensive range of high-quality antibodies. The company’s aim is to provide quality tools to accelerate the bioscience research community.
It has been said that the partnership will enable increased efficiencies through consolidation of all Bio-Techne’s consumable products through one channel, In Vitro Technologies. Users can purchase Novus Biologicals, R&D Systems, Tocris and Boston Biochem products all from one place.
In Vitro Technologies says its extensive life science portfolio provides the company with the technical expertise to empower users through the evolution of their research. Users are encouraged to talk to one of the company’s applications specialised product managers and build a customised solution from its cell biology portfolio, including brands such as ATCC, HyClone, Falcon and Corning in addition to the Bio-Techne range.
A pre-emptive approach to treating leukaemia relapse
The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...
Long COVID abnormalities appear to resolve over time
Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...
RNA-targeted therapy shows promise for childhood dementia
Scientists have shown that a new RNA-targeted therapy can halt the progression of a specific type...